Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy.
Exp. Gerontol., Jul;46(7):549-59 (2011)
Treatment of pulmonary arterial hypertension with circulating angiogenic cells.
Am. J. Physiol. Lung Cell Mol. Physiol., Jul;301(1):L12-9 (2011)
Closure of a para-valvular aortic leak: with the use of 2 AMPLATZER devices and real-time 2- and 3-dimensional transesophageal echocardiography.
Tex Heart Inst J., 38(1):81-4 (2011)
Sterile radial artery granuloma after transradial cardiac catheterization.
Cardiovasc Revasc Med., 12(3):187-9 (2011)
Atherosclerotic renal artery stenosis--diagnosis and treatment.
Mayo Clin. Proc., Jul;86(7):649-57 (2011)
Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.
Sci Transl Med., Sep;3(100):100ra90 (2011)
A murine model of isolated cardiac steatosis leads to cardiomyopathy.
Hypertension., Feb;57(2):216-22 (2011)
Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.
Circulation., Oct;124(17):1838-47 (2011)
Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.
Cytotherapy., Feb;14(2):223-31 (2012)
Advanced Donor Age Impairs Bone Marrow Cell Therapeutic Efficacy for Cardiac Disease.
J Tissue Sci Eng., Nov;S3 (2011)
A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model.
Int J Cardiovasc Imaging., Jun;26(5):509-18 (2010)
Making a smooth vascular exit--does your kidney function matter?
J Invasive Cardiol., Jan;22(1):13-4 (2010)
Cardiac CT and percutaneous mitral annuloplasty: a vision of the future?
J Invasive Cardiol., Feb;22(2):74-5 (2010)
Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.
Mol. Ther., Jul;17(7):1250-6 (2009)
Granulocyte colony stimulating factor in myocardial infarction with low ejection fraction.
Cytokine., Sep;51(3):278-85 (2010)
Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction.
J. Card. Fail., Jul;16(7):579-89 (2010)
Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction.
Cardiovasc. Pathol., 20(4):204-12 (2011)
Cytokine combination therapy with long-acting erythropoietin and granulocyte colony stimulating factor improves cardiac function but is not superior than monotherapy in a mouse model of acute myocardial infarction.
J. Card. Fail., Aug;16(8):669-78 (2010)
Nitric oxide synthase expression and functional response to nitric oxide are both important modulators of circulating angiogenic cell response to angiogenic stimuli.
Arterioscler. Thromb. Vasc. Biol., Nov;30(11):2212-8 (2010)
Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction.
Cardiovasc Drugs Ther., Dec;24(5-6):409-20 (2010)